Abstract
Human movement drives the transmission and spread of communicable pathogens. It is especially influential for emerging pathogens when population immunity is low and spillover events are rare. We digitized serial printed maps to measure transportation networks (roads and rivers) in Central and West Africa as proxies for population mobility to assess relationships between movement and Ebola transmission. We find that the lengths of roads and rivers in close proximity to spillover sites at or near the time of spillover events are significantly correlated with the number of EVD cases, particularly in the first 100 days of each outbreak. Early management and containment efforts along transportation networks may be beneficial in mitigation during the early days of transmission and spatial spread for Ebola outbreaks.
Significance Statement This study links human movement and pathogen transmission across fifty years. While this relationship is well understood for modern outbreaks, it has not been characterized at local scales for historical outbreaks. We compared the number of cases and the spatial spread of each documented outbreak of Ebola (Orthoebolavirus zairense, EBOV) to the road and river networks surrounding each spillover location at the time of each spillover event. We measured the road and river networks by digitizing a series of paper maps that were printed during or near the year of each spillover. We show that the connectivity of spillover locations is consistently correlated to the severity of the outbreak over time and across all locations of EBOV spillover events.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the joint National Institutes of Health (NIH) - National Science Foundation (NSF) - National Institute of Food and Agriculture (NIFA) Ecology and Evolution of Infectious Disease (award R01TW012434 to NB), NSF RAPID (award 2202872 to NB), and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), NIH (1ZIAAI001179-01 to VM). SNS was partly supported by funding to Verena (viralemergence.org) from the NSF (award BII 2021909 and BII 2213854). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
All authors declare no competing interests.
Data availability
Hard copies of all Michelin maps used in this study are available at the Donald W. Hamer Center for Maps and Geospatial Information in the Penn State University Pattee Library. Digital copies and code used for analyses are available at https://github.com/bhartilab/EbolaMaps.
